Evidence map›Paper›PMID 23706898›Full record

ReviewCurrent opinion in neurobiology2013

Sites of action of sleep and wake drugs: insights from model organisms.

Jason Rihel, Alexander F Schier

Abstract readReview
In one paragraph

Review in Current opinion in neurobiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Modeling the Exposome in Murine Cardiovascular Disease.JACC. Basic to translational science · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. The origins and evolution of sleep.The Journal of experimental biology · 2018
    Review
  7. Review
  8. Review
  9. Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Review
  10. Review
  11. Article
  12. Article
  13. Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Synthetic biology for pharmaceutical drug discovery.Drug design, development and therapy · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Jason RihelDepartment of Cell and Developmental Biology, University College London, Gower Street, London WC1E 6BT, UK. Electronic address: j.rihel@ucl.ac.uk.
Alexander F Schier
Harvard University · USUniversity College London · GB

Funding

Genetics of Sleep in ZebrafishR01HL109525 · NHLBI · HARVARD UNIVERSITY · PI SCHIER, ALEXANDER F · 2011 to 2015
$2.1M
Genetics of Sleep in ZebrafishR01GM085357 · NIGMS · HARVARD UNIVERSITY · PI SCHIER, ALEXANDER F · 2008 to 2010
$1.0M
Generation of Hypocretin Neurons from Narcoleptic PatientsR21NS071598 · NINDS · HARVARD UNIVERSITY · PI SCHIER, ALEXANDER F · 2010 to 2011
$457k
European Research Council 282027NHLBI NIH HHS R01 HL109525NIGMS NIH HHS R01 GM085357NINDS NIH HHS R21 NS071598
6 · The paper itself

Abstract

Small molecules have been used since antiquity to regulate our sleep. Despite the explosion of diverse drugs to treat problems of too much or too little sleep, the detailed mechanisms of action and especially the neuronal targets by which these compounds alter human behavioural states are not well understood. Research efforts in model systems such as mouse, zebrafish and fruit fly are combining conditional genetics and optogenetics with pharmacology to map the effects of sleep-promoting drugs onto neural circuits. Recent studies raise the possibility that many small molecules alter sleep and wake via specific sets of critical neurons rather than through the global modulation of multiple brain targets. These findings also uncover novel brain areas as sleep/wake regulators and indicate that the development of circuit-selective drugs might alleviate sleep disorders with fewer side effects.

Indexed as

AnimalsBrainHumansSleepWakefulness

Identifiers

PMID23706898
PMCPMC3783591
OpenAlexW2139810582

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.